Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Anti-Scarring Topical Paste Reduces Radiation Fibrosis

By HospiMedica International staff writers
Posted on 17 Jan 2016
A new study suggests that topical application of an A2A receptor (A2AR) antagonist prevents radiation dermatitis, and may be useful in the reduction of fibrotic changes in the skin.

Researchers at NYU Langone Medical Center (New York, NY, USA) conducted a study in mice to test if blocking the A2AR site could prevent radiation-induced fibrosis, a side effect experienced by as many as 95% of patients undergoing initial radiation treatment. More...
To do so, they exposed mice to a single dose of 40 Gy, an amount of radiation similar to a five week radiation therapy treatment protocol. Some of the irradiated animals were normal; some were genetically engineered to lack A2AR, while others were treated with the A2AR antagonist ZM241385.

The results showed that in irradiated normal mice treated with the A2AR antagonist there was a marked reduction in collagen content, myofibroblast cells, angiogenesis, and density of collagen fibrils. Epidermal thickness due to an increasing the number of proliferating keratinocytes was also prevented by ZM241385. Similar changes were seen in the A2AR genetically modified mice. The study was published in the January 2016 edition of the Journal of the Federation of American Societies for Experimental Biology (FASEB).

“A2A antagonist drugs could also be used in treating other diseases involving changes in the structure of collagen, a major component of skin and connective tissues, such as scleroderma and interstitial pulmonary fibrosis,” said senior author Prof. Bruce Cronstein, MD, director of the NYU Langone Clinical and Translational Science Institute. “Such therapies are badly needed because very few drugs are currently available to treat fibrosis, and those that are on the market are not very effective.”

Radiation dermatitis is a cutaneous lesion induced by ionizing radiation, which ranges from a mild rash to severe ulceration, with approximately 85% of all patients treated with radiation therapy (RT) experiencing a moderate-to-severe skin reaction. Once considered to be a major risk of conventional RT, it has become less common and less severe since the 1970s, with the development of high- and medium-energy accelerators.

Related Links:

NYU Langone Medical Center



Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Monitor/Defibrillator
Zenix
Immobilization System
Cranial 4Pi Immobilization
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image Credit: Shutterstock

Explainable AI Examines Sepsis Mortality Risk and Emergency Care Delays

Preventing sepsis-related deaths in emergency departments (EDs) remains challenging because patient deterioration can result from multiple rapidly evolving and interconnected factors. These include triage... Read more

Patient Care

view channel
Image: A view inside the custom virtual reality environment used in the study: a calm room with a teddy bear, soft colors and large windows looking out over the sea. (Image Credit: Walaa S. Abu Rukbah et al., Virginia Commonwealth University; CC-BY 4.0, https://creativecommons.org/licenses/by/4.0/)

Virtual Reality Program May Reduce Anxiety Before Pediatric Surgery

Presurgery anxiety affects an estimated 50% to 75% of children undergoing surgery and can complicate anesthesia induction, increase postoperative pain, and prolong recovery. Sedation is often used to manage... Read more

Health IT

view channel
Image Credit: Shutterstock

Telemonitoring Program Improves Quality of Life After Heart Failure Discharge

Heart failure is a chronic condition associated with high mortality, frequent hospitalizations, and reduced quality of life. Patients face particularly high risks of readmission and death after discharge,... Read more

Point of Care

view channel
Image: Jessica Ramella-Roman, professor of biomedical engineering at Florida International University, holding the PPRIM (Portable Preterm Imaging) device designed to detect early signs of preterm labor risk. (Photo courtesy of Florida International University)

Handheld Imaging Device May Help Identify Preterm Birth Risk Earlier

Preterm birth, defined as delivery before 37 weeks of pregnancy, can lead to serious neonatal complications, including neurological, developmental, and respiratory problems. However, identifying pregnancies... Read more

Business

view channel
Image: Stryker has acquired ZuriMED, adding the FiberLocker System, a rotator cuff augmentation technology designed to strengthen repairs, to its Sports Medicine portfolio. (Photo courtesy of ZuriMED)

Stryker Completes Acquisition to Broaden Shoulder Surgery Offerings

Stryker (Portage, MI, USA) has completed its acquisition of ZuriMED (Zurich, Switzerland), a privately held developer of the FiberLocker System, expanding its Sports Medicine portfolio with a commercialized... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.